{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T21:53:22Z","timestamp":1713995602516},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,9,13]],"date-time":"2006-09-13T00:00:00Z","timestamp":1158105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2006,10,25]]},"DOI":"10.1007\/s00296-006-0214-4","type":"journal-article","created":{"date-parts":[[2006,9,12]],"date-time":"2006-09-12T09:02:08Z","timestamp":1158051728000},"page":"39-43","source":"Crossref","is-referenced-by-count":10,"title":["Decreased protein S activity is related to the disease activity of Behcet\u2019s disease"],"prefix":"10.1007","volume":"27","author":[{"given":"Seong Ryul","family":"Kwon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mie Jin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin Goo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Sook","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,9,13]]},"reference":[{"key":"214_CR1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0049-0172(98)80001-2","volume":"27","author":"VG Kaklamani","year":"1998","unstructured":"Kaklamani VG, Vaiopoulos G, Kaklamanis PG (1998) Behcet\u2019s disease. Semin Arthritis Rheum 27:197\u2013217","journal-title":"Semin Arthritis Rheum"},{"key":"214_CR2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1600-0609.1981.tb01424.x","volume":"25","author":"C Kluft","year":"1980","unstructured":"Kluft C, Michiels JJ, Wijngaards G (1980) Factual or artificial inhibition of fibrinolysis and the occurrence of venous thrombosis in 3 cases of Behcet\u2019s disease. Scand J Haematol 25:423\u2013430","journal-title":"Scand J Haematol"},{"key":"214_CR3","first-page":"402","volume":"19","author":"Y Koc","year":"1992","unstructured":"Koc Y, Gullu I, Akpek G, Akpolat T, Kiraz S, Batman F et al (1992) Vascular involvement in Behcet\u2019s disease. J Rheumatol 19:402\u2013410","journal-title":"J Rheumatol"},{"key":"214_CR4","first-page":"341","volume":"19","author":"JT Lie","year":"1992","unstructured":"Lie JT (1992) Vascular involvement in Behcet\u2019s disease: arterial and venous and vessels of all sizes. J Rheumatol 19:341\u2013343","journal-title":"J Rheumatol"},{"key":"214_CR5","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1212\/WNL.42.3.614","volume":"42","author":"B Wechsler","year":"1992","unstructured":"Wechsler B, Vidailhet M, Piette JC, Bousser MG, Dell IB, Blentry O et al (1992) Cerebral venous thrombosis in Behcet\u2019s disease: clinical study and long-term follow-up of 25 cases. Neurol 42:614\u2013618","journal-title":"Neurol"},{"key":"214_CR6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0038-1646409","volume":"66","author":"KK Hampton","year":"1991","unstructured":"Hampton KK, Chamberlain MA, Menon DK, Davis JA (1991) Coagulation and fibrinolytic activity in Behcet\u2019s disease. Thromb Haemost 66:292\u2013294","journal-title":"Thromb Haemost"},{"key":"214_CR7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3109\/03009749509095184","volume":"24","author":"K Ozoran","year":"1995","unstructured":"Ozoran K, Duzgun N, Gurler A, Tutkak H, Tokgoz G (1995) Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behcet\u2019s disease. Scand J Rheumatol 24:376\u2013382","journal-title":"Scand J Rheumatol"},{"key":"214_CR8","first-page":"496","volume":"25","author":"AF Oner","year":"1998","unstructured":"Oner AF, Gurgey A, Gurler A, Mesci L (1998) Factor V Leiden mutation in patients with Behcet\u2019s disease. J Rheumatol 25:496\u2013498","journal-title":"J Rheumatol"},{"key":"214_CR9","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/rheumatology\/35.11.1178","volume":"35","author":"A Gul","year":"1996","unstructured":"Gul A, Ozbek U, Ozturk C, Inanc M, Konkce M, Ozcelik T (1996) Coagulation factor V mutation increases the risk of venous thrombosis in Behcet\u2019s disease. Br J Rheumatol 35:1178\u20131180","journal-title":"Br J Rheumatol"},{"key":"214_CR10","first-page":"2404","volume":"26","author":"R Mader","year":"1992","unstructured":"Mader R, Ziv M, Adawi M, Mader R, Lavi I (1992) Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behcet\u2019s disease. J Rheumatol 26:2404\u20132408","journal-title":"J Rheumatol"},{"key":"214_CR11","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s002680010282","volume":"24","author":"N Sengul","year":"2000","unstructured":"Sengul N, Demirer S, Yerdel MA, Terzioglu G, Akin B, Gurler A et al (2000) Comparison of coagulation parameters for healthy subject and Behcet\u2019s disease patients with and without vascular involvement. World J Surg 24:1584\u20131588","journal-title":"World J Surg"},{"key":"214_CR12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1053\/ejvs.2000.1091","volume":"19","author":"S Demier","year":"2000","unstructured":"Demier S, Sengul N, Yerder MA, Tuzuner A, Ulus AT, Gurler A et al (2000) Haemostatis in patients with Behcet\u2019s disease. Eur J Vasc Endovasc Surg 19:570\u2013574","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"214_CR13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-0038-1657551","volume":"78","author":"D Borgel","year":"1997","unstructured":"Borgel D, Gandrille S, Aiach M (1997) Protein S deficiency. Thromb Haemost 78:351\u2013356","journal-title":"Thromb Haemost"},{"key":"214_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0303-8467(99)00076-1","volume":"102","author":"JH Lee","year":"2000","unstructured":"Lee JH, Kim SW, Kim JS (2000) Sagittal sinus thrombosis associated with transient free protein S deficiency after l-asparaginase treatment: case report and review of the literature. Clin Neurol Neurosurg 102:33\u201336","journal-title":"Clin Neurol Neurosurg"},{"key":"214_CR15","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1056\/NEJM199306173282405","volume":"328","author":"A D\u2019Angelo","year":"1993","unstructured":"D\u2019Angelo A, Valle PD, Crippa L, Pattarini E, Grimaldi L, D\u2019Angelo SV (1993) Autoimmune protein S deficiency in a boy with severe thromboemblimc disease. N Engl J med 328:1753\u20131757","journal-title":"N Engl J med"},{"key":"214_CR16","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1182\/blood.V81.7.1801.1801","volume":"81","author":"CP Stahl","year":"1993","unstructured":"Stahl CP, Wideman CS, Spira TJ, Haff EC, Hixon GJ, Evatt BL (1993) Protein S deficiency in men with long-term human immunodeficiency virus infection. Blood 81:1801\u20131807","journal-title":"Blood"},{"key":"214_CR17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/BF02190684","volume":"153","author":"P Nguyen","year":"1994","unstructured":"Nguyen P, Reynaud J, Pouzol P, Munzer M, Richard O, Francois P (1994) Varicella and thrombotic complications associated with transient protein C and protein S deficiencies in children. Eur J Pediatr 153:646\u2013649","journal-title":"Eur J Pediatr"},{"key":"214_CR18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1096-8652(199604)51:4<319::AID-AJH12>3.0.CO;2-9","volume":"51","author":"SR Deitcher","year":"1996","unstructured":"Deitcher SR, Erban JK, Limentani SA (1996) Acquired free protein S deficiency associated with multiple myeloma: a case report. Am J Hematol 51:319\u2013323","journal-title":"Am J Hematol"},{"key":"214_CR19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/1529-0131(200003)43:3<557::AID-ANR11>3.0.CO;2-O","volume":"43","author":"KS Song","year":"2000","unstructured":"Song KS, Park YS, Kim HK (2000) Prevalence of anti-protein S antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 43:557\u2013560","journal-title":"Arthritis Rheum"},{"key":"214_CR20","first-page":"1078","volume":"335","author":"International Study Group for Behcet\u2019s Disease","year":"1990","unstructured":"International Study Group for Behcet\u2019s Disease (1990) Criteria for diagnosis of Behcet\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"214_CR21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/rheumatology\/keg453","volume":"43","author":"G Lawton","year":"2004","unstructured":"Lawton G, Bhakta BB, Chamberlain MA, Tennant A (2004) The Behcet\u2019s Disease activity index. Rheumatol 43:73\u201378","journal-title":"Rheumatol"},{"key":"214_CR22","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1073\/pnas.83.18.6716","volume":"83","author":"A Lundwall","year":"1986","unstructured":"Lundwall A, Dackowski W, Cohen E, Shaffer M, Mahr A, Dahlback B et al (1986) Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation. Proc Natl Acad Sci USA 83:6716\u20136720","journal-title":"Proc Natl Acad Sci USA"},{"key":"214_CR23","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.4049\/jimmunol.169.5.2580","volume":"169","author":"JH Webb","year":"2002","unstructured":"Webb JH, Blom AM, Dahlback B (2002) Vitamin K-dependent protein S localizing complement regulator C4b-binding protein to the surface of apoptotic cells. J Immunol 169:2580\u20132586","journal-title":"J Immunol"},{"key":"214_CR24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ni871","volume":"4","author":"HA Anderson","year":"2003","unstructured":"Anderson HA, Maylock CA, Williams JA, Paweletz CP, Shu H, Shacter E (2003) Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat immunol 4:87\u201391","journal-title":"Nat immunol"},{"issue":"Suppl 1","key":"214_CR25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000248445","volume":"179","author":"K Ohkohchi","year":"1989","unstructured":"Ohkohchi K, Tornuki W, Tagami H (1989) Plasma concentration of complement-modulation proteins (C1 inhibitor, C4 binding protein, factor H and factor I) in inflammatory dermatoses with special reference to psoriasis. Dermatologica 179(Suppl 1):30\u201334","journal-title":"Dermatologica"},{"key":"214_CR26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/03009749709115831","volume":"26","author":"HA Kim","year":"1997","unstructured":"Kim HA, Choi KW, Song YW (1997) Arthropathy in Behcet\u2019s disease. Scand J Rheumatol 26:125\u2013129","journal-title":"Scand J Rheumatol"},{"key":"214_CR27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0049-3848(02)00085-3","volume":"106","author":"YJ Lee","year":"2002","unstructured":"Lee YJ, Kang SW, Yang JI, Choi YM, Sheen D, Lee EB et al (2002) Coagulation parameters and plasma total homocysteine levels in Behcet\u2019s disease. Thromb Res 106:19\u201324","journal-title":"Thromb Res"},{"key":"214_CR28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00296-001-0143-1","volume":"21","author":"D Ozatli","year":"2002","unstructured":"Ozatli D, Sayinalp N, Buyukasik Y, Karakus S, Haznedaroglu IC, Kirazli S et al (2002) Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behcet\u2019s disease: evidence of a prethrombotic state. Rheumatol Int 21:137\u2013140","journal-title":"Rheumatol Int"},{"key":"214_CR29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.2004.06003.x","volume":"151","author":"C Yazici","year":"2004","unstructured":"Yazici C, Kose K, Calis M, Demlr M, Kirnap M, Ates F (2004) Increased advanced oxidation protein products in Behcet\u2019s disease: a new activity marker? Br J Dermatol 151:105\u2013111","journal-title":"Br J Dermatol"},{"issue":"Suppl 34","key":"214_CR30","first-page":"S17","volume":"22","author":"N Duzgun","year":"2004","unstructured":"Duzgun N, Ayaslioglu E, Tutkak H (2004) Serum soluble CD30 levels in Behcet\u2019s disease. Clin Exp Rheumatol 22(Suppl 34):S17\u201320","journal-title":"Clin Exp Rheumatol"},{"key":"214_CR31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00290374","volume":"15","author":"K Ozoran","year":"1996","unstructured":"Ozoran K, Duzgun N, Tutkak H, Gurler A, Tokgoz G (1996) Fibronectin and circulation immune complexes in Behcet\u2019s disease. Rheumatol Int 15:221\u2013224","journal-title":"Rheumatol Int"},{"key":"214_CR32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3346\/jkms.2002.17.3.371","volume":"17","author":"HK Chang","year":"2002","unstructured":"Chang HK, Cheon KS (2002) The clinical significance of a pathergy reaction in patients with Behcet\u2019s disease. J Korean Med Sci 17:371\u2013374","journal-title":"J Korean Med Sci"},{"key":"214_CR33","first-page":"374","volume":"38","author":"V Hamuryndan","year":"1999","unstructured":"Hamuryndan V, Fresko I, Direskeneli H, Tenant MJ, Yurdakul S, Akoglu T et al (1999) Evaluation of the Turkish translation of a disease activity form for Behcet\u2019s syndrome. Rheumatol 38:374\u2013376","journal-title":"Rheumatol"},{"key":"214_CR34","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/rheumatology\/38.8.728","volume":"38","author":"BB Bhakta","year":"1999","unstructured":"Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ (1999) Behcet\u2019s disease: evaluation of a new instrument to measure clinical activity. Rheumatol 38:728\u2013733","journal-title":"Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-006-0214-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-006-0214-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-006-0214-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T05:39:23Z","timestamp":1587188363000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-006-0214-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,13]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,10,25]]}},"alternative-id":["214"],"URL":"https:\/\/doi.org\/10.1007\/s00296-006-0214-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,13]]}}}